#AUA2024 great turnout for the MD Anderson Department of Urology alumni gathering at the Fairmont rooftop bar. #oncsurgery Brian F. Chapin

🔥 HOT OFF THE PRESS: Happy to share the results of *two* Phase 2 studies of cabozantinib in #AdrenalCancer in The Lancet Oncology from MD Anderson Cancer Center

Scroll down for more details ⬇️ #GUSM #GUOncology

Proud to sponsor this walk by our affiliate Chris Johnson Foundation Inc., who's tireless advocacy for #RMC is truly inspiring. See you on the 23rd!!

Excited to share our new paper just published Nature Communications WCM GU Cancer Weill Cornell Medicine nature.com/articles/s4146… Great collaboration between my lab with Olivier Elemento WCM Englander Institute for Precision Medicine and J.M. Mosquera Weill Cornell Medicine Pathology 🔬 Full tweetorial below with more updates to come. Stay tuned!

Looking forward to my visit to Koch Institute at MIT Massachusetts Institute of Technology (MIT)
Thanks Francisco J. Sánchez-Rivera for the invitation

Leaving ASCO #GU24 with much gratitude for many meaningful moments and ready to get back to work together against #bladdercancer 💪Weill Cornell Medicine. One such moment is conversation with oncology superstars Toni Choueiri, MD Tom Powles in the speaker ready room before my talk!

Thanks UroToday.com for highlighting our work presented ASCO #GU24

What the future holds? Dr. Bishoy Faltas Dr. Bishoy M. Faltas just delivered stunning data on integrating AI into bladder cancer management at ASCO #GU24

Only 9 weeks before the big event.
It's time to dust off those tennis shoes and get ready for the 11th Annual Keepin' It Renal Run/Walk.
Registration available at: chrisjohnsonfoundation.org/11th-annual-5k…
Sponsorship available at: chrisjohnsonfoundation.org/11th-annual-5k…

1/7 Six papers published in 2023 that improved our understanding of #RenalMedullaryCarcinoma : this study connected hypoxia & SMARCB1 loss in the medulla of individuals with #SickleCellTrait elucidating a key mechanism of resistance to anti-VEGF treatment: pubmed.ncbi.nlm.nih.gov/37186844/

JUST IN and again via ASCO #FDAAlerts

The FDA Oncology approved Enfortumab Vedotin ( EV) in combo with pembrolizumab for metastatic urothelial cancer!!

Data based on Tom Powles #ESMO23 Plenary (EV-302) #StandingOvation ESMO - Eur. Oncology

Great day for Bladder Cancer and our…

JUST IN: U.S. FDA approved belzutifan (HIF2 inhibitor) in advanced renal cell carcinoma (RCC) following PD1 and VEGF inhibitors!

A great day for the field and a new option for our Kidney Cancer patients!!!!

Via ASCO #FDAAlerts OncoAlert

Study presented at ESMO - Eur. Oncology #ESMO3 by…

An interesting case we came across University of Texas Houston Urologic Surgery of metastatic renal cell carcinoma initially presenting as recurrent epistaxis Kyle A. Blum, MD, MS JU Open Plus
journals.lww.com/juop/fulltext/…

🚨 AUA Testis Cancer Guideline Update Journal of Urology

👉 Primary RPLND added to options (XRT or Chemo) for Early Metastatic Pure Seminoma (stage IIA-B w/ LN < 3 cm)

⁦Amer. Urol. Assn.⁩ auajournals.org/doi/10.1097/JU…

Thoroughly enjoyed working on this paper with Andy Hahn Shilpa Surasi Paul Viscuse, MD Tharak Bathala Eric Jonasch Sangeeta Goswami, MD,PhD Priya Rao, MD et al. on the responses of sarcomatoid and/or rhabdoid #kidneycancer to contemporary targeted agents after progression on immunotherapy.

Today, the Chris CJ Johnson Foundation achieved a significant connection by bringing together two patients of similar age who reside in different states- What united them was a shared diagnosis of Renal Medullary Carcinoma (RMC). Pavlos Msaouel
#EndRMC

It took Kyle A. Blum, MD, MS 6 years of work to develop this sarcomatoid RCC consortium. Willing to bet that breakthroughs regarding this aggressive RCC phenotype are going to culminate from his hard work!

Future MD Anderson Cancer Center Society of Urologic Oncology fellow Elizabeth Ellis MD, MS highlighting translational kidney work identifying regulators of purinergic signaling within the tumor microenvironment of ccRCC 🤓

Don’t know what that is? Dr. Ellis is here to explain. Come check it out.

#SUO23 YUO

Surgeon-scientist Allison May, MD giving an awesome talk on optimizing a fellowship experience.

Valuable lessons on how to select mentors, leveraging your interests, & prioritizing the important things in life.

Transparent, real, honest.

YUO Society of Urologic Oncology Amer. Urol. Assn. #SUO23

Amazing talk by ⭐️ Allison May, MD ⭐️ on professional development and lessons learned during YUO Society of Urologic Oncology fellowship. Incredible wisdom and advice. #SUO23